Orladeyo: payments to doctors
Payments that named Orladeyo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.1M
- Providers
- 4,431
- Transactions
- 27,861
- Average per transaction
- $112
The per-transaction average — $112 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,431 providers the average total is $702, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Biocryst US Sales Co., LLC | $2,782,818 | 89.4% |
| Biocryst Pharmaceuticals, Inc. | $329,099 | 10.6% |